ATE533765T1 - Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung - Google Patents

Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung

Info

Publication number
ATE533765T1
ATE533765T1 AT05808813T AT05808813T ATE533765T1 AT E533765 T1 ATE533765 T1 AT E533765T1 AT 05808813 T AT05808813 T AT 05808813T AT 05808813 T AT05808813 T AT 05808813T AT E533765 T1 ATE533765 T1 AT E533765T1
Authority
AT
Austria
Prior art keywords
derivatives
pyrroloä2
cüpyridine
production
pharmaceutically acceptable
Prior art date
Application number
AT05808813T
Other languages
English (en)
Inventor
Jae-Gyu Kim
Byung-Nak Ahn
Hyouk-Woo Lee
Suk-Won Yoon
Young-Ae Yoon
Dong-Hoon Kim
Chan-Sun Park
Seok-Hee Han
Myung-Hun Cha
Heui-Il Kang
Ryong Choi
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of ATE533765T1 publication Critical patent/ATE533765T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05808813T 2004-09-03 2005-09-03 Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung ATE533765T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040070533 2004-09-03
PCT/KR2005/002927 WO2006025716A1 (en) 2004-09-03 2005-09-03 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE533765T1 true ATE533765T1 (de) 2011-12-15

Family

ID=36000318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05808813T ATE533765T1 (de) 2004-09-03 2005-09-03 Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung

Country Status (17)

Country Link
US (2) US7662832B2 (de)
EP (1) EP1784404B1 (de)
JP (1) JP4898683B2 (de)
KR (3) KR100958829B1 (de)
CN (1) CN101018789B (de)
AT (1) ATE533765T1 (de)
AU (1) AU2005280740B2 (de)
BR (1) BRPI0514925A (de)
CA (1) CA2579087C (de)
DK (1) DK1784404T3 (de)
ES (1) ES2373672T3 (de)
HK (1) HK1105979A1 (de)
MX (1) MX2007002324A (de)
PL (1) PL1784404T3 (de)
PT (1) PT1784404E (de)
RU (1) RU2385320C2 (de)
WO (2) WO2006025717A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070053231A (ko) † 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
CA2579087C (en) * 2004-09-03 2012-05-01 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
US7906528B2 (en) * 2004-10-05 2011-03-15 Novartis International Pharmaceutical Ltd. Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
GB0525143D0 (en) * 2005-12-09 2006-01-18 Novartis Ag Organic compounds
EP2452680B1 (de) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Säurepumpenantagonist zur behandlung von mit unnormalen magen-darm-bewegungen assoziierten erkrankungen
CN102875549B (zh) * 2012-09-14 2015-11-04 浙江大学 7-芳（甲）胺基-5-胺基-6-氮杂吲哚衍生物及制备与用途
US9045477B2 (en) * 2013-03-15 2015-06-02 Epizyme, Inc. Substituted 6,5-fused bicyclic heteroaryl compounds
KR101657597B1 (ko) * 2013-05-08 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
KR101657599B1 (ko) * 2013-05-20 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
BG111544A (bg) 2013-07-29 2015-01-30 Николай Цветков Субституирани бензамидни производни като in vitro mao-b инхибитори
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
KR102129842B1 (ko) * 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
WO2015125858A1 (ja) * 2014-02-24 2015-08-27 日本曹達株式会社 ヘテロアリール化合物およびその用途
CN105440016B (zh) * 2014-08-11 2018-08-31 江苏柯菲平医药股份有限公司 吲哚、氮杂吲哚类衍生物、其制备方法及其在医药上的应用
MA41850A (fr) 2015-03-31 2018-02-06 Takeda Pharmaceuticals Co Nouvelles utilisations pharmaceutiques
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
UA124764C2 (uk) * 2016-04-15 2021-11-17 Еббві Інк. Інгібітори бромодомену
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
CN108164455A (zh) * 2017-03-23 2018-06-15 广东众生药业股份有限公司 马来酸非尼拉敏的合成方法
KR102233456B1 (ko) * 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN110117284B (zh) * 2018-02-06 2021-11-19 江苏奥赛康药业有限公司 含氮杂环类化合物及其制备方法和用途
CN112300170B (zh) * 2019-07-26 2022-01-21 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用
CN112300169B (zh) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4428962A (en) * 1981-10-30 1984-01-31 Schering Corporation Indoles in treatment of peptic ulcers
JPH0611670A (ja) * 1992-06-25 1994-01-21 Hitachi Ltd 光強度変調素子および光強度変調器
JP3465827B2 (ja) * 1993-02-24 2003-11-10 株式会社日清製粉グループ本社 アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
JP3143571B2 (ja) * 1994-01-19 2001-03-07 三共株式会社 ピロロピリダジン誘導体
DE69530989T2 (de) 1994-08-13 2004-05-19 Yuhan Corp. Neue pyrimidinderivate und verfahren zu ihrer herstellung
GB2298199A (en) * 1995-02-21 1996-08-28 Merck Sharp & Dohme Synthesis of azaindoles
FR2732969B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) * 1997-11-28 1997-11-28 Astra Ab New compounds
IL142063A0 (en) 1998-09-23 2002-03-10 Byk Gulden Lomberg Chem Fab Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
KR20070034049A (ko) * 2004-06-09 2007-03-27 글락소 그룹 리미티드 피롤로피리딘 유도체
KR20070053231A (ko) * 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
CA2579087C (en) * 2004-09-03 2012-05-01 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
KR100958829B1 (ko) 2010-05-25
CA2579087A1 (en) 2006-03-09
EP1784404B1 (de) 2011-11-16
HK1105979A1 (en) 2008-02-29
CA2579087C (en) 2012-05-01
WO2006025717A1 (en) 2006-03-09
BRPI0514925A (pt) 2008-07-01
US7662832B2 (en) 2010-02-16
US8188114B2 (en) 2012-05-29
KR20060051005A (ko) 2006-05-19
JP2008511621A (ja) 2008-04-17
US20100069430A1 (en) 2010-03-18
KR20060051006A (ko) 2006-05-19
KR100958830B1 (ko) 2010-05-24
KR20100039325A (ko) 2010-04-15
CN101018789B (zh) 2010-09-08
KR101049068B1 (ko) 2011-07-15
MX2007002324A (es) 2007-05-11
CN101018789A (zh) 2007-08-15
PL1784404T3 (pl) 2012-04-30
RU2007112110A (ru) 2008-10-10
AU2005280740B2 (en) 2011-04-28
WO2006025716A1 (en) 2006-03-09
ES2373672T3 (es) 2012-02-07
EP1784404A1 (de) 2007-05-16
RU2385320C2 (ru) 2010-03-27
AU2005280740A1 (en) 2006-03-09
US20070219230A1 (en) 2007-09-20
JP4898683B2 (ja) 2012-03-21
PT1784404E (pt) 2011-12-09
DK1784404T3 (da) 2012-02-13
EP1784404A4 (de) 2009-09-09

Similar Documents

Publication Publication Date Title
ATE533765T1 (de) Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung
ATE518858T1 (de) Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
WO2009115517A3 (en) Pyridines and pyrazines as inhibitors of pi3k
TNSN05194A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2006099943A8 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2007120647A3 (en) Compositions useful as inhibitors of voltage-gated sodium channels
NO20070339L (no) 1-aza-bicyklo[3 3.1]nonaner
WO2003084922A8 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
GEP20074055B (en) Nicotinamide derivatives useful as pde4 inhibitors
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
WO2006065590A3 (en) Pyridine and pyrimidine antiviral compositions
WO2007053844A3 (en) Compositions and methods for treating inflammatory disorders
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2006052886A8 (en) Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
WO2007072092A3 (en) New phenanthridine derivatives as bradykinin antagonists
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
WO2006072000A3 (en) Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
ATE466013T1 (de) Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
WO2006061380A3 (en) SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION
WO2006004903A3 (en) 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
ECSP077307A (es) Derivados piridínicos de indolin-2-ona, su preparación y su aplicación en terapéutica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1784404

Country of ref document: EP